480 related articles for article (PubMed ID: 23871637)
1. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.
Masiero M; Simões FC; Han HD; Snell C; Peterkin T; Bridges E; Mangala LS; Wu SY; Pradeep S; Li D; Han C; Dalton H; Lopez-Berestein G; Tuynman JB; Mortensen N; Li JL; Patient R; Sood AK; Banham AH; Harris AL; Buffa FM
Cancer Cell; 2013 Aug; 24(2):229-41. PubMed ID: 23871637
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.
Favara DM; Liebscher I; Jazayeri A; Nambiar M; Sheldon H; Banham AH; Harris AL
Sci Rep; 2021 Apr; 11(1):8870. PubMed ID: 33893326
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor 124 (GPR124) in endothelial cells regulates vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.
Wang Y; Cho SG; Wu X; Siwko S; Liu M
Curr Mol Med; 2014 May; 14(4):543-54. PubMed ID: 24730523
[TBL] [Abstract][Full Text] [Related]
5. ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.
Sheldon H; Alexander J; Bridges E; Moreira L; Reilly S; Ang KH; Wang D; Lin S; Haider S; Banham AH; Harris AL
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681953
[TBL] [Abstract][Full Text] [Related]
6. Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
Niinivirta M; Georganaki M; Enblad G; Lindskog C; Dimberg A; Ullenhag GJ
BMC Cancer; 2020 Apr; 20(1):339. PubMed ID: 32321460
[TBL] [Abstract][Full Text] [Related]
7. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
8. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
[TBL] [Abstract][Full Text] [Related]
9. ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
Huang H; Georganaki M; Conze LL; Laviña B; van Hooren L; Vemuri K; van de Walle T; Ramachandran M; Zhang L; Pontén F; Bergqvist M; Smits A; Betsholtz C; Dejana E; Magnusson PU; He L; Lugano R; Dimberg A
Neuro Oncol; 2022 Mar; 24(3):398-411. PubMed ID: 34347079
[TBL] [Abstract][Full Text] [Related]
10. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
[TBL] [Abstract][Full Text] [Related]
11. Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor.
Wyder L; Suply T; Ricoux B; Billy E; Schnell C; Baumgarten BU; Maira SM; Koelbing C; Ferretti M; Kinzel B; Müller M; Seuwen K; Ludwig MG
Angiogenesis; 2011 Dec; 14(4):533-44. PubMed ID: 22045552
[TBL] [Abstract][Full Text] [Related]
12. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
13. A review of ELTD1, a pro-angiogenic adhesion GPCR.
Favara DM; Banham AH; Harris AL
Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586
[TBL] [Abstract][Full Text] [Related]
14. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
16. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
17. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.
Shih SC; Zukauskas A; Li D; Liu G; Ang LH; Nagy JA; Brown LF; Dvorak HF
Cancer Res; 2009 Apr; 69(8):3272-7. PubMed ID: 19351819
[TBL] [Abstract][Full Text] [Related]
18. IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4.
Deng J; Liu X; Rong L; Ni C; Li X; Yang W; Lu Y; Yan X; Qin C; Zhang L; Qin Z
J Pathol; 2014 Jun; 233(2):170-82. PubMed ID: 24615277
[TBL] [Abstract][Full Text] [Related]
19. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
20. Tie-1: A potential target for anti-angiogenesis therapy.
Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
